Home
Company
About us
Genito-urinary diseases
Governance
Board of Directors
Scientific Advisory Board
Team
R&D
Pipeline
Litoxetine (IXA-001)
IXA-002 & IXA-003
MAGenTA
Press
Contact
Team
Home
/
Team
Executive Team
Roberto Gradnik
CEO
Nathalie de Valleuil
Finance
Development team
Elisabeth Svanberg
Chief Development Officer
Dr Mario Pellegatti
Non-clinical Pharmacokinetics expert
Dr. Nigel Roome
MSc, PhD Non clinical toxicology expert
Business development team
Melya Hughes Crameri
PhD, EPA
Mikael Oerum